Tower Research Capital LLC (TRC)
Position in MIRA — Mira Pharmaceuticals, Inc.
CIK 1533421
NEW YORK, NY
Position in MIRA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$489
-$4,835 QoQ
Shares Held
517
-89.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 26 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MIRA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $110,167,581 across 17 Drug Manufacturers - General names. MIRA ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,448 | $32,921,956 | |
| 2 | GSK |
GSK plc
|
463,125 | $24,277,011 | |
| 3 | NVO |
Novo Nordisk A S
|
314,106 | $15,058,240 | |
| 4 | JNJ |
Johnson & Johnson
|
38,358 | $9,741,780 | |
| 5 | ABBV |
AbbVie Inc.
|
28,379 | $7,141,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,245 | $5,463,573 | |
| 7 | MRK |
Merck & Co., Inc.
|
37,782 | $4,854,986 | |
| 8 | AMGN |
Amgen Inc
|
12,238 | $4,431,624 |
All Filings in MIRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489 | 517 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $5,324 | 4,976 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,763 | 1,830 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,443 | 1,797 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $7,867 | 6,901 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||